Search

everythinglearnresearchcommunity

for

Search:↓

Doctors should consider Netherton syndrome in patients with chronic skin and hair issues to avoid misdiagnosis.

Boys with less severe EDA mutations in XLHED have milder symptoms and better sweat and hair production.

Scientists now better understand the genetics of hypohidrotic ectodermal dysplasia, leading to more accurate diagnoses and potential new treatments.

A 38-year-old African American woman has a rare condition that prevents her from growing long hair.

Using SNP array testing helped quickly find the gene causing Woodhouse-Sakati syndrome in two related individuals.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

A new gene variant in the DSP gene is linked to a unique type of hair loss.

WNT10A mutations often cause ectodermal dysplasias, with males showing more tooth issues than females.

Hair shaft dysplasias are abnormal hair conditions that can be inherited or acquired and may signal other health issues, with limited treatment options available.

Children's hair grows in different types from before birth through puberty, with growth rates and characteristics varying by age, sex, and race.

Oral minoxidil shows promise in treating monilethrix-related hair loss.

A patient with a rare hair condition and skin disorder showed hair improvement after treatment.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Monilethrix causes fragile, patchy hair loss.

Mutations in the HEPHL1 gene cause abnormal hair and cognitive issues.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The document concludes that the girl's hairlessness is likely inherited from her parents.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

Some skin diseases and their treatments can negatively affect male fertility.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

Hair, teeth, and mammary glands develop similarly at first but use different genes later.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Trichoscopy and trichogram are useful for diagnosing hair and scalp conditions.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Researchers found a new mutation in the HR gene linked to a rare hair loss condition.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.